3/16
09:00 am
dsgn
Design Therapeutics (DSGN) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.
Medium
Report
Design Therapeutics (DSGN) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.
3/15
09:52 am
dsgn
Design Therapeutics Maps H2 Data Readouts for RESTORE-FA, FECD Biomarker Study and DM1 Program [Yahoo! Finance]
Medium
Report
Design Therapeutics Maps H2 Data Readouts for RESTORE-FA, FECD Biomarker Study and DM1 Program [Yahoo! Finance]
3/10
09:47 am
dsgn
Design Therapeutics (DSGN) had its price target raised by Royal Bank Of Canada from $13.00 to $14.00. They now have an "outperform" rating on the stock.
Medium
Report
Design Therapeutics (DSGN) had its price target raised by Royal Bank Of Canada from $13.00 to $14.00. They now have an "outperform" rating on the stock.
3/9
04:23 pm
dsgn
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates [Yahoo! Finance]
Medium
Report
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates [Yahoo! Finance]
3/9
04:01 pm
dsgn
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates
Medium
Report
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates
2/18
08:49 am
dsgn
Design Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Design Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/18
08:00 am
dsgn
Design Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Design Therapeutics to Participate in Upcoming Investor Conferences
2/14
01:32 am
dsgn
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at
Wall Stree
Low
Report
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at
Wall Stree
1/17
01:11 am
dsgn
Design Therapeutics (NASDAQ:DSGN) was downgraded by analysts at
Wall Str
Medium
Report
Design Therapeutics (NASDAQ:DSGN) was downgraded by analysts at
Wall Str
1/7
07:18 am
dsgn
Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
High
Report
Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
1/3
01:08 am
dsgn
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at
Wall Stree
Medium
Report
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at
Wall Stree